Insider at issuer (NASDAQ: MDLZ) plans 3,000-share stock sale

Rhea-AI Filing Summary

An affiliate of the issuer filed a notice of proposed sale on Form 144 covering 3,000 shares of common stock, with an aggregate market value of $185,580.00. The shares are expected to be sold around 02/13/2026 on the NASDAQ through Morgan Stanley Smith Barney LLC Executive Financial Services. The issuer had 1,281,845,669 shares outstanding at the time referenced. The shares to be sold were acquired on 02/12/2025 as restricted stock units from the issuer. By signing, the seller represents they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3000	185580.00	1281845669	02/13/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/12/2025	Restricted Stock Units	Issuer			3000	02/12/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the MDLZ Form 144 filing report?

The Form 144 filing reports a proposed sale of 3,000 shares of common stock with an aggregate market value of $185,580.00. The shares were acquired as restricted stock units on 02/12/2025 and are planned for sale on the NASDAQ.

How many MDLZ shares are proposed for sale and at what value?

The filing covers a proposed sale of 3,000 common shares with an aggregate market value of $185,580.00. These shares will be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on the NASDAQ exchange, according to the notice.

When were the MDLZ shares being sold under Form 144 acquired?

The 3,000 MDLZ common shares were acquired on 02/12/2025 as restricted stock units from the issuer. This acquisition date and the RSU nature of the transaction are disclosed in the Form 144 securities acquisition table.

What is the planned sale date for the MDLZ shares in this Form 144?

The notice lists an approximate sale date of 02/13/2026 for the 3,000 common shares. The sale is expected to occur on the NASDAQ exchange through the named broker, subject to market conditions and Rule 144 requirements.

How many MDLZ shares are outstanding compared to the Form 144 sale?

The issuer had 1,281,845,669 shares of common stock outstanding at the referenced time. The Form 144 sale covers 3,000 shares, a very small portion of the total outstanding shares disclosed in the filing.

Which broker is handling the MDLZ Form 144 share sale?

The proposed sale of 3,000 MDLZ common shares will be handled by Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004, as stated in the Form 144 broker information section.